申请人:Pfizer Inc.
公开号:US20150087585A1
公开(公告)日:2015-03-26
Derivatives of purine, 3H-imidazo[4,5-b]pyrimidine and 1H-imidazo[4,5-d]pyrazine of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
本文描述了嘌呤的衍生物,Formula I的3H-咪唑并[4,5-b]嘧啶和1H-咪唑并[4,5-d]吡嗪,它们抑制二酰基甘油酰基转移酶2(DGAT2)的活性,并在动物治疗相关疾病中的用途。